# Vivaldi Biosciences Inc: Form D filing

Vivaldi Biosciences Inc, a biotechnology company in New York, NY, filed a Form D with the SEC in 2010. The latest, on July 7, 2010, reports $2 million sold of an offering with no set size to 4 investors.

Find out what Vivaldi Biosciences Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vivaldi%20Biosciences%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vivaldi%20Biosciences%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fvivaldi-biosciences-inc-1398022)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vivaldi%20Biosciences%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vivaldi%20Biosciences%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fvivaldi-biosciences-inc-1398022)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: BELLEVUE HOSPITAL CENTER, 462 First Avenue, Bldg. A, Ste. 908, New York, NY, 10016
- Phone: (646) 381-6680
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2006
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1398022

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 7, 2010 | New notice | Indefinite | $1,974,546 | Indefinite | 4 | Jul 2, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1398022/000139802210000003/0001398022-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Douglass Given | Executive Officer, Director |  |
| Elliott O. Kieff, M.D. | Promoter |  |
| N/A O. Bay City Capital Fund IV Co-Investment Fund, L.P. | Promoter |  |
| Vic Schmitt | Director |  |
| William Gerber | Director |  |
| N/A O. Bay City Capital Fund IV, L.P. | Promoter |  |
| Georg Nebgen | Director |  |
| Peter O. Palese, Ph.D. | Promoter |  |
| N/A O. Scheer Investment Holdings IX LLC | Promoter |  |
| Peter Johann | Director |  |
| William O. Wick, Jr. | Executive Officer, Promoter |  |
| David Liebowitz | Executive Officer, Promoter |  |
| N/A O. Douglass B. and Kim Given Revocable Trust, U/A/D 8/11/01 | Promoter |  |
| Adolfo O. Garcia-Sastre, Ph.D. | Promoter |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Jul 5, 2010](https://specstream.ai/data/form-d/week/2010-07-05) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Vivaldi Biosciences Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).